Virus-specific CTL are an important factor in the control and elimination ofviral infections (1-10). These cells recognize viral antigen in association with H-2 class I, or in some instances, class II molecules (1, 11, 12) . In recent years, there has been considerable progress in documenting the biological significance of CTL and in defining and mapping the antigenic epitopes recognized by such cells (1-16). However, relatively little is known about the life span of virus-specific CTL.
and their spleen and LN cells tested for the presence of LCMV-specific CTL after stimulation with virus for 8 d in vivo (in irradiated mice) . About 2-5 x 10' pooled spleen and LN cells from treated carrier mice (Thy-1.1 -Thy-1 .2) were injected intravenously into normal mice irradiated (650 rad) 1 or 2 d previously. Unless otherwise stated, these irradiated recipient mice were B6Thy-1 .2. At the time of cell transfer, irradiated recipients were challenged intravenously with 105 PFU of LCMV Arm 7. 8 d later, the recipient mice were killed and the spleen and axillary, inguinal, and cervical LNs were harvested and assayed for CTL activity. The phenotype (Thy-1.1 or Thy-l .2) ofthe CTL was determined by complement-mediated depletion using Thy-1.1-and Thy-1 .2-specific mAbs as described previously (21) .
T Cell Depletion. To deplete donor T cells, spleen and LN cells from cured carrier mice were treated in vitro with antiThy-1 .1 (Tn-26) plus C' and transferred intravenously into irradiated recipients for in vivo stimulation. The irradiated recipients were injected intraperitoneally with 0.5 ml of 19EL2 at the time of cell transfer and again on day +2 and +3 to further deplete donor T cells in vivo. The depletion of host T cells was accomplished in vitro with two rounds of antiThy-1 .2 (HO-13-4) plus C: CD4' T cells were depleted in vitro with two rounds of RL172 .4 plus Cand the remaining spleen and LN cells were transferred intravenously into irradiated mice. CD4' cells were then further depleted by injecting the irradiated recipients with 0.5 ml of GK1 .5 at the time ofcell transfer and again on day 3 .
LCMV-specific CTLAssay. Single-cell suspensions of spleen and lymph nodes, free oferythrocytes, were prepared in complete RPMI medium supplemented with 10To heat-inactivated FCS, antibiotics, and L-glutamine. The cells were then tested for cytotoxicity on uninfected, LCMVinfected, or Pichinde virus-infected MC57 (H-2b) or BALB CL-7 (H-2d) fibroblasts . MC57 cells were infected 48 h before use with the indicated virus at a multiplicity ofinfection of 0.5 PFU/cell. BALB CL-7 cells were infected at a multiplicity of infection of 0.5 PFU with the indicated virus 24 h before use. The target cells were labeled with "Cr and the cytotoxicity assay was performed as previously described (6) . Test duration was 6 h and samples were run in triplicate. The percent specific 
Results
Long-term Persistence ofAdoptively Transferred LCMV-specific CTL. The lifelong chronic LCMV infection of congenitally infected carrier mice can be eliminated by adoptive transfer of CD8+ , MHC class I-restricted, virus-specific T cells derived from adult immune mice (10, 17, 18, 22) . To determine the life span of the donor T cell population in the cured carrier host, we examined the time course during which donorderived T cells and donor cytotoxic T cell activity could be recovered . To allow us to identify the donor T cells and to distinguish between their activity and the activity of the host T cells, we used mice congenic at the Thy-1 locus in adoptive transfer experiments . Immune cells from B6.Thy-1.1 (donor) mice were adoptively transferred into B6.Thy-1 .2 carrier (host) mice. Viral clearance from treated carrier mice was then monitored by determining the level of infectious virus in blood and several other tissues. At various times post-transfer, mice with no detectable viremia were killed and the presence of LCMVspecific CTL activity was checked in their spleen and LN cells. Freshly isolated lymphocytes from treated carrier mice did not exhibit CTL activity and showed minimal or no killing of virally infected cells (data not shown). However, an LCMV-specific CTL response was readily detectable when these lymphocytes were stimulated with virus for 8 d in irradiated recipient mice. This protocol of in vivo stimulation with virus was used in all experiments to monitor.the presence of virus-specific CTL in treated carrier mice. The data from several such experiments are summarized in Fig . 1 and details of one particular experiment are shown in Table I . As demonstrated in Fig. 1 , an LCMV-specific CTL response was FIGURE 1. Persistence of donor-derived LCMV specific CTL (Thy-1 .1) in carrier mice (Thy-1.2). Spleen and LN cells were harvested from cured carrier mice (Thy-1 .2) at the indicated times after transfer of immune T cells (Thy-1 .1) and tested for CTL activity after in vivo stimulation with virus as described in Materials and Methods. The phenotype (Thy-1 .1 or Thy-1.2) of the CTL was determined by complement-mediated depletion usingThyl .l-and Thy1 .2-specific mAbs . The data shown is percent specific killing of infected targets at an E/T ratio of 50 : 1 . easily detectable and most of the killing was mediated by the donor Thy-1.1 T cells present in cured carrier mice . Donor-derived CTL activity was present at all time points checked and could be recovered as late as 274 d post-transfer. Although there is some variation in the magnitude of the response, no decline in CTL activity was observed at the later time points . Table I shows in detail recovery of donor Thy-1 .1 CTL activity from cured carrier mice 274 d post-transfer. Depletion of host Thy-1 .2+ T cells from the effector population had no effect on the magnitude of the CTL response . In contrast, depletion of either donor Thy-1.1+ or CD8+ T cells completely abrogated LCMV specific cytotoxicity, demonstrating that the effectors were CD8+ T cells ofdonor Thy-1.1 origin . These results show that as late as 274 d post-transfer, donor Thy-1 .1 T cells are still present in the cured carrier host and retain CTL activity against LCMV. The CD8 + Thy-1.1' T cells were MHC class I restricted (no killing of LCMVinfected H-2d cells) and virus specific as they did not lyse uninfected or Pichinde virus-infected H-2b targets (data not shown) .
Long-lived Donor T Cells Retain In Vivo Antiviral Activity against LCMV. In addition to mediating in vitro CTL activity, these long-lived donor T cells are biologically active in vivo and can eliminate virus from a second infected recipient . When Thy-1 .1+ donor T cells isolated from cured carrier mice are transferred into irradiated mice infected with LCMV, they can control the viral infection. The results of one such experiment are shown in Table II . No detectable virus was found in mice that received the Thy-1.1 T cells, in contrast to the high levels of infectious LCMV in organs of irradiated mice receiving virus but no cells .
In Vivo Proliferation of Long-lived Donor CD8+ T Cells. The cured carrier spleens and LNs were examined by flow cytometry for the relative percentages of donor and host CD4' and CD8+ T cells both before and after in vivo stimulation with LCMV. Single cell suspensions of pre-and post-stimulation lymphocytes were costained for the Thy-1 .1 or Thy-1.2 antigen and either the CD4 or CD8 surface marker (see Materials and Methods). Although the donor T cells represented only a minor population of the freshly isolated resting lymphocytes from cured carrier mice, this population underwent tremendous expansion when stimulated with LCMV The results presented in Fig. 2 and Table III show that this expansion of donor T cells occurred almost exclusively within the donor CD8+ subset . In experiment 1 (see Fig. 2 and Table III The data from experiment 2 (Table III) Table IV , depletion of CD4+ T cells had no detectable effect on the proliferation of donor CD8+ T cells and minimal to no effect on the generation of LCMV specific CTL responses and viral clearance. Depletion of CD4' T cells was quite effective and there were <1% CD4+ T cells in the CD4-depleted mice as determined by flow cytometry. Despite this reduction in number of CD4+ T cells, the average numbers of lymphocytes recovered per irradiated recipient were equal for both the CD4-depleted and mock-treated groups (data not shown) . The equal proliferation, the potent CTL response, and effective viral clearance by the CD8+ cells in the C134-depleted group demonstrates a minimal requirement for CD4+ T cells in the induction of the anti-LCMV activities of these long-lived donor CD8+ T cells.
Immunodominance of Donor T Cells over Host-derived LCMV-specific CTL Response. We have previously reported that the cured carrier mice can make a host-derived (Thy-1.2) LCMVspecific CTL response (21) . In these earlier studies, donor (Thy-1 .1) T cells Spleen and LN cells from nine cured carrier mice (95 d post-transfer of Thy-1 .1' T cells) were pooled and then divided into two groups of equal numbers of cells . To deplete CD4' T cells (CD4-depleted group), cells were treated in vitro with two rounds of RL172 .4 plus C' and transferred intravenously into infected irradiated mice for in vivo stimulation with LCMV . Each irradiated recipient was injected intraperitoneally with 0 .5 mg of GK1 .5 at the time of cell transfer and again on day 3 to further deplete any remaining CD4' T cells . In the mock group cells were treated twice in vitro with C' only before transfer into irradiated recipients . Proliferation of CD8' T cells, LCMV-specific CTL response, and virus titers were determined 8 d postinfection as described in Materials and Methods . had been depleted by in vivo treatment of cured carrier mice with an mAb against Thy-1 .1 (19E1 .2) before testing the host CTL response (21) . In the results presented in this paper, as shown in Fig. 1 and Table I , stimulation of cured carrier lymphocytes containing both donor and host T cells resulted in the generation of CTL responses mediated predominantly by donor T cells. These findings suggested the dominance of the donor CTL response over the generation of host CTL activity. This hypothesis was tested by the following experiment . Spleen and LN cells from cured carrier mice were pooled and then divided into four groups containing equal numbers of cells. From one group, donor T cells were depleted, from one, host T cells, from one, both host and donor T cells, and one group was mock treated (i .e., no cells depleted). These four cell populations were then tested for their ability to generate an LCMV specific CTL response and to determine ifit is mediated by host or donor T cells. As shown in Fig. 3 , a host (Thy-1 .2)-derived LCMVspecific CTL response was observed only in the donor T cell-depleted group. When both host and donor T cells were present ("no depletion" group) the donor (Thy-1 .1) CTL response was dominant over the potential CTL response of the cured carrier host . This experiment has been repeated two additional times with similar results (data not shown) .
Discussion This study provides direct evidence that virus-specific CTL can persist indefinitely in vivo. This was accomplished by transferring Thy-1 .1 T cells into Thy-1.2 recipient mice to specifically identify the donor T cell population and to characterize its antigenic specificity and function by using a virus-specific CTL assay. The transferred LCMVspecific CTL persist in the recipient mice in small numbers and comprise only a minor fraction ofthe total T cells. But on exposure to virus these cells proliferate in vivo to become the predominant cell population . These CD8+ T cells can be recovered up to a year post-transfer and still retain antigenic specificity and biological function . They kill LCMVinfected cells in vitro and can eliminate virus upon transfer into a second infected host. These results strongly suggest that virus-specific CTL can persist for the life span of the host as memory cells.
In several instances natural infections, such as with measles virus, varicella, etc., and also vaccinations with certain viruses, result in long-lived T cell immunity (23) (24) (25) . However, it is not clear if this is due to persistence of the initially primed T cells and their progeny, or due to subsequent re-exposure to virus and the priming of new (virgin) T cells. By adoptively transferring marked (Thy-1 .1) mature T cells from LCMV immune mice into Thy-1 .2 recipients, we have unequivocally shown that primed virus-specific CTL and/or their progeny can indeed persist for a long and indefinite period of time. Thus, our results show that priming of new T cells is not necessary for maintaining long-term T cell immunity.
In our experiments we have examined the longevity ofvirus-specific CTL in cured carrier mice, which at the time ofadoptive transfer contained vast amounts of virus. With the exception of the kidney, no viral antigen was detectable in the tissues of the cured carrier mice at the time donor T cells were recovered. However, we cannot rule out the possibility that the presence of minute amounts of viral antigen not detectable by conventional assays, or virus within the kidney, provides continuous antigenic stimulation to the donor T cells causing proliferation and maintenance ofthis T cell population . It will be ofinterest to determine if these long-lived LCMVspecific CTL require antigen for their persistence. A recent study examining haptenspecific antibody responses has shown that B cell memory is short lived in the absence of antigen (26) . Experiments are currently in progress to investigate the life span of virus-specific CTL in an antigen "free" environment.
Our study also provides direct evidence for the in vivo proliferation of CD8+ T cells during the induction of a CTL response. This is in contrast to the accepted view of cytotoxic T cell development, in which proliferation is thought to occur primarily within the CD4+ T cell population with CD8+ T cells undergoing only limited expansion (27) . Several months after adoptive transfer, the donor CD8+ T cells represented only a minor population (2.0-3 .0% ofthe total spleen and LN cells) of the freshly isolated resting lymphocytes from cured carrier mice . However, after in vivo stimulation with virus, these cells expanded at least 5-10-fold in number to become the predominant T cell population (27.4-52 .0% of the total cells) . In addition, the virus-specific CTL activity resided almost exclusively within this subset of cells (i.e., Thy-1.1 + CD8 + cells) . Taken together, these results suggest that memory CTL are present in small numbers in a "resting" stage and are capable of expansion after exposure to viral antigen.
Our data also suggest that these long-lived CD8+ CTL are not dependent on help from CD4+ T cells, since depletion of CD4+ T cells had minimal or no effect on the biological properties (proliferation, CTL response, viral clearance) of the donor CD8+ T cells. These results extend our previous finding that the primary CTL response against LCMV does not require CD4+ T cells (28) . Thus, it appears that both the primary and memory LCMVspecific CTL responses can function in the absence of CD4' T cells. It is possible that these long-lived CD8+ CTL are autocrine in nature and capable of producing the lymphokines necessary for their own growth and activation . Alternatively, in the absence of CD4+ T cells, help may be provided by CD8 + helper cells within the donor and/or host T cell population . The existence of CD8' Th cells and the ability ofCD8+ T cells to produce IL-2 has been shown in several systems (29) (30) (31) .
Virus-specific CTL unresponsiveness is a hallmark of the LCMV carrier state (6, 21, 22, 32, 33) . In this report, we have again demonstrated that mice cured of congenitally acquired chronic LCMV infection can generate a host-derived virusspecific CTL response. This confirms our recent finding that mice previously in-fected by and unresponsive to the virus can become immunocompetent and are then protected against reinfection (21) . The present study also extends the earlier finding by showing that despite the ability ofthe cured carrier host to generate a competent LCMVspecific CTL response, donor-derived T cells must be removed before stimulation of cured carrier lymphocytes before a significant host CTL response can be detected . This clearly demonstrates the dominance of the long-lived donor T cells over the host response . This finding could be explained as the dominance of a secondary (donor) vs. a primary (host) response. A differential requirement by primary and secondary populations for lymphokines and antigens has been described for MLCs (34) . Primary host T cells may have more stringent requirements for lymphokines or antigenic stimulation than the secondary donor T cell population . In addition, donor CTL precursors (CTLp) may exist in higher numbers than host CTLp . Thus, the higher precursor frequencies and/or differential lymphokine requirements would allow the donor cells to proliferate and respond more rapidly than the host, therefore, competing more successfully for antigen and growth factors required to activate the host CTLp . This would allow the donor population to effectively deal with the virus before the host cells were extensively exposed and stimulated.
T cell immunity is crucial in defense against viral, parasitic, and intracellular bacterial infections, and also in surveillance of tumors (35) (36) (37) . Failure of T cell immunity often leads to chronic infections . Our results showing that antigen-specific CTL can persist indefinitely and retain the ability to mediate viral clearance has implications towards understanding the immunological mechanisms effective in controlling chronic infections and tumors . It is conceivable that one of the limiting factors in the successful resolution of certain chronic infections are these long-lived T cells capable of persisting and mediating clearance for months or even years. Strategies to restore and/or increase the function and numbers of such T cells may be effective in the treatment of chronic infections .
Immunological memory is one ofthe most fascinating but least understood aspects of the immune system . A major obstacle in studying T cell memory has been the difficulty in obtaining "pure" populations of in vivo generated and selected memory cells. The system we have developed may allow us to overcome this problem. Based on our results, it is highly likely that the majority of Thy-1 .1+ CD8 + T cells that persist in cured carrier mice (Thy-1 .2) are LCMV specific . Thus, it is possible to obtain a highly enriched population of in vivo selected memory CTL and to examine their biological and physical characteristics . This should allow us to address some fundamental questions about memory T cells.
Summary
This study documents that virus-specific CTL can persist indefinitely in vivo. This was accomplished by transferring Thy-1 .1 T cells into Thy-1.2 recipient mice to specifically identify the donor T cell population and to characterize its antigenic specificity and function by using a virus-specific CTL assay. Thy-1.1 * T cells from mice previously immunized with lymphocytic choriomeningitis virus (LCMV) were transferred into Thy-1.2 mice persistently infected with LCMV. The transferred LCMVspecific CTL (Thy-1 .1+ CD8+) eliminate virus from the chronically infected carriers and persist in the recipient mice in small numbers, comprising only a minor fraction of the total T cells. Upon re-exposure to virus, these long-lived "resting" CD8' T cells proliferate in vivo to become the predominant cell population . These donor CD8+ T cells can be recovered up to a year post-transfer and still retain antigenic specificity and biological function. They kill LCMV infected H-2-matched cells in vitro and can eliminate virus upon transfer into a second infected host. In addition, these long-lived CD8' T cells appear not to be dependent on help from CD4' T cells, since depletion of CD4+ T cells has minimal or no effect on their biological properties (proliferation, CTL response, viral clearance) . These donor CTL also exhibit an immunodominance over the host-derived LCMVspecific CTL response . When both host and donor T cells are present, the donor CTL response is dominant over the potential CTL response of the cured carrier host. Taken together, these results suggest that virus-specific CTL can persist for the life span of the host as memory cells .
